Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

Summary

The purpose of the study is to determine the reduction of LDL-cholesterol level after treatment with 50 mg per day of lapaquistat acetate once daily (QD).

Timeline

Start

2007-10

Primary completion

2008-05

Completion

2008-05

Outcome

Outcome not reported

Stopped: “Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents”

Drugs

Indications